FdaApplication

ANDA 216814

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASCENT PHARMACEUTICALS INC
application_typeANDA
approval_date2023-03-15

Products (1)

ProductActive ingredientStrengthDosage form
IBUPROFEN AND FAMOTIDINEFAMOTIDINE; IBUPROFEN26.6MG;800MGTABLET;ORAL

1 product